Stay updated with breaking news from Scientific Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Many people believe or have likened diabetes to a death sentence, that when one has it, it would be difficult to recover from or totally eliminate it. Diabetes Mellitus continues to be among the Top 5 causes of death in the Philippines. From January to May of last year, deaths…
A drug targeting mRNA essential for APO C-III production provided a 50% reduction in triglycerides in BRIDGE-TIMI 73a, the largest ever observed in a controlled trial.
The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), being held April 6-8 in Atltanta, GA. An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovascular disease, and this prevalence is unchanged over time.
Alberto Foà, MD, PhD, discusses a PARAGON-HF analysis from ACC.24 examining treatment-related hypotension in people with HFmrEF/HFpEF.
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.